ELV Elevance Health Inc
- Stocks
- Healthcare
- NYSE: ELV
Price (delayed)
$408.31
Market cap
$92.25B
P/E Ratio
15.83
Dividend/share
$6.6
EPS
$25.8
Enterprise value
$114.75B
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately
Highlights
ELV's P/E is 11% below its 5-year quarterly average of 17.7 and 8% below its last 4 quarters average of 17.2
The company's revenue rose by 7% YoY and by 3.6% QoQ
Elevance Health's debt has increased by 13% YoY but it has decreased by 3.9% from the previous quarter
ELV's gross margin is down by 6% year-on-year and by 2.4% since the previous quarter
Elevance Health's net income has decreased by 5% YoY
Key stats
What are the main financial stats of ELV
Market
Valuations
Earnings
Shares outstanding
225.93M
Market cap
$92.25B
Enterprise value
$114.75B
Price to earnings (P/E)
15.83
Price to book (P/B)
2.18
Price to sales (P/S)
0.51
EV/EBIT
12.7
EV/EBITDA
10.96
EV/Sales
0.63
Revenue
$183.33B
Gross profit
$30.08B
Operating income
$9.03B
Net income
$5.92B
EBIT
$9.04B
EBITDA
$10.47B
Free cash flow
$3.67B
Per share
Balance sheet
Liquidity
EPS
$25.8
EPS diluted
$25.69
Free cash flow per share
$16.16
Book value per share
$186.95
Revenue per share
$806.35
TBVPS
$349.05
Total assets
$119.72B
Total liabilities
$77.1B
Debt
$30B
Equity
$42.5B
Working capital
$18.42B
Debt to equity
0.71
Current ratio
1.43
Quick ratio
1.31
Net debt/EBITDA
2.15
Margins
Efficiency
Dividend
EBITDA margin
5.7%
Gross margin
16.4%
Net margin
3.2%
Operating margin
4.9%
Return on assets
5.1%
Return on equity
13.9%
Return on invested capital
15.6%
Return on capital employed
11.7%
Return on sales
4.9%
Dividend yield
1.62%
DPS
$6.6
Payout ratio
25.6%
ELV stock price
How has the Elevance Health stock price performed over time
Intraday
-2.92%
1 week
-4.78%
1 month
-5.63%
1 year
-22.2%
YTD
10.68%
QTD
-6.13%
Financial performance
How have Elevance Health's revenue and profit performed over time
Revenue
$183.33B
Gross profit
$30.08B
Operating income
$9.03B
Net income
$5.92B
Gross margin
16.4%
Net margin
3.2%
Elevance Health's net margin has decreased by 11% YoY and by 6% from the previous quarter
The operating margin has declined by 8% year-on-year and by 3.9% since the previous quarter
The company's revenue rose by 7% YoY and by 3.6% QoQ
ELV's gross margin is down by 6% year-on-year and by 2.4% since the previous quarter
Growth
What is Elevance Health's growth rate over time
Valuation
What is Elevance Health stock price valuation
P/E
15.83
P/B
2.18
P/S
0.51
EV/EBIT
12.7
EV/EBITDA
10.96
EV/Sales
0.63
ELV's P/E is 11% below its 5-year quarterly average of 17.7 and 8% below its last 4 quarters average of 17.2
Elevance Health's EPS has decreased by 3.2% YoY
ELV's price to book (P/B) is 19% lower than its 5-year quarterly average of 2.7 and 13% lower than its last 4 quarters average of 2.5
The equity has increased by 4.7% YoY and by 2.9% from the previous quarter
ELV's P/S is 27% below its 5-year quarterly average of 0.7 and 15% below its last 4 quarters average of 0.6
The company's revenue rose by 7% YoY and by 3.6% QoQ
Efficiency
How efficient is Elevance Health business performance
Elevance Health's ROIC has decreased by 17% YoY and by 4.3% from the previous quarter
ELV's ROE is down by 13% YoY and by 2.1% QoQ
Elevance Health's return on assets has decreased by 11% YoY
Elevance Health's return on sales has decreased by 8% YoY and by 3.9% QoQ
Dividends
What is ELV's dividend history
DPS
$6.6
Dividend yield
1.62%
Payout ratio
25.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Elevance Health financials performed over time
The total assets is 55% higher than the total liabilities
The total liabilities is up by 8% year-on-year and by 2.2% since the previous quarter
The total assets rose by 7% YoY and by 2.4% QoQ
Elevance Health's debt is 29% less than its equity
Elevance Health's debt has increased by 13% YoY but it has decreased by 3.9% from the previous quarter
The debt to equity is up by 9% year-on-year but it has declined by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.